My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 138

    1.

    Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma.

    Gutterman JU, Blumenschein GR, Alexanian R, Yap HY, Buzdar AU, Cabanillas F, Hortobagyi GN, Hersh EM, Rasmussen SL, Harmon M, Kramer M, Pestka S.

    Ann Intern Med. 1980 Sep;93(3):399-406.PMID: 6159812 [PubMed - indexed for MEDLINE]Related articles

    2.

    Collaborative phase I-II study of recombinant DNA-produced leukocyte interferon (clone A) in metastatic breast cancer, malignant lymphoma, and multiple myeloma.

    Quesada JR, Hawkins M, Horning S, Alexanian R, Borden E, Merigan T, Adams F, Gutterman JU.

    Am J Med. 1984 Sep;77(3):427-32.PMID: 6548079 [PubMed - indexed for MEDLINE]Related articles

    3.

    Clinical results of leukocyte interferon-induced tumor regression in resistant human metastatic cancer resistant to chemotherapy and/or radiotherapy-pulse therapy schedule.

    Medenica R, Slack N.

    Cancer Drug Deliv. 1985 Winter;2(1):53-76.PMID: 4052926 [PubMed - indexed for MEDLINE]Related articles

    4.

    Clinical study of recombinant DNA-produced leukocyte interferon (clone A) in a intermittent schedule in cancer patients.

    Quesada JR, Gutterman JU.

    J Natl Cancer Inst. 1983 Jun;70(6):1041-6.PMID: 6190033 [PubMed - indexed for MEDLINE]Related articles

    5.

    Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.

    Hagenbeek A, Carde P, Meerwaldt JH, Somers R, Thomas J, De Bock R, Raemaekers JM, van Hoof A, De Wolf-Peeters C, van Glabbeke M.

    J Clin Oncol. 1998 Jan;16(1):41-7.PMID: 9440721 [PubMed - indexed for MEDLINE]Related articles

    6.

    Antitumor activity of thalidomide in refractory multiple myeloma.

    Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, Munshi N, Anaissie E, Wilson C, Dhodapkar M, Zeddis J, Barlogie B.

    N Engl J Med. 1999 Nov 18;341(21):1565-71. Erratum in: N Engl J Med 2000 Feb 3;342(5):364. PMID: 10564685 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    [Clinical trial of human lymphoblastoid interferon on advanced malignancy]

    Usui N, Ogawa M, Inagaki J, Horikoshi N, Inoue K, Miyamoto H, Ikeda K, Nakada H, Adachi K, Okada Y, et al.

    Gan To Kagaku Ryoho. 1983 Nov;10(11):2324-9. Japanese. PMID: 6357102 [PubMed - indexed for MEDLINE]Related articles

    8.

    Interferons in the treatment of multiple myeloma.

    Ohno R.

    Int J Cancer Suppl. 1987;1:14-20.PMID: 2442112 [PubMed - indexed for MEDLINE]Related articles

    9.

    Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease.

    Schiffman KS, Bensinger WI, Appelbaum FR, Rowley S, Lilleby K, Clift RA, Weaver CH, Demirer T, Sanders JE, Petersdorf S, Gooley T, Weiden P, Zuckerman N, Montgomery P, Maziarz R, Klarnet JP, Rivkin S, Trueblood K, Storb R, Holmberg L, Buckner CD.

    Bone Marrow Transplant. 1996 Jun;17(6):943-50.PMID: 8807098 [PubMed - indexed for MEDLINE]Related articles

    10.

    Follow-up observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma.

    Louie AC, Gallagher JG, Sikora K, Levy R, Rosenberg SA, Merigan TC.

    Blood. 1981 Oct;58(4):712-8.PMID: 6168319 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    [Treatment of hematological malignancies with recombinant leukocyte A interferon (rIFN-alpha A)]

    Ohno R, Kodera Y, Ogura M, Murase T, Emi N, Okumura M, Morishita Y, Nagura E, Minami S, Morishima Y, et al.

    Gan To Kagaku Ryoho. 1984 Dec;11(12 Pt 1):2531-6. Japanese. PMID: 6594973 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Clinical effects of human lymphoblastoid interferon in patients with hematologic neoplasms]

    Oda Y, Irie S, Inagaki M, Fukumoto M, Ueda I, Ohmoto E, Fujimoto S, Endo Y, Watanabe S, Lai M, Takahashi I, Kimura I, Ishii H, Sezaki T.

    Gan To Kagaku Ryoho. 1983 May;10(5):1313-9. Japanese. PMID: 6575725 [PubMed - indexed for MEDLINE]Related articles

    13.

    Recombinant leukocyte A interferon in advanced breast cancer. Results of a phase II efficacy trial.

    Sherwin SA, Mayer D, Ochs JJ, Abrams PG, Knost JA, Foon KA, Fein S, Oldham RK.

    Ann Intern Med. 1983 May;98(5 Pt 1):598-602.PMID: 6342490 [PubMed - indexed for MEDLINE]Related articles

    14.

    Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.

    Ozer H, Gavigan M, O'Malley J, Thompson D, Dadey B, Nussbaum-Blumenson A, Snider C, Rudnick S, Ferraresi R, Norred S, et al.

    J Biol Response Mod. 1983;2(6):499-515.PMID: 6607323 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in hematological malignancies]

    [No authors listed]

    Gan To Kagaku Ryoho. 1985 Apr;12(4):928-35. Japanese. PMID: 3885864 [PubMed - indexed for MEDLINE]Related articles

    16.

    Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients.

    Gutterman JU, Fine S, Quesada J, Horning SJ, Levine JF, Alexanian R, Bernhardt L, Kramer M, Spiegel H, Colburn W, Trown P, Merigan T, Dziewanowski Z.

    Ann Intern Med. 1982 May;96(5):549-56.PMID: 6176159 [PubMed - indexed for MEDLINE]Related articles

    17.

    Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.

    Engelhardt M, Winkler J, Waller C, Lange W, Mertelsmann R, Henschler R.

    Bone Marrow Transplant. 1997 Mar;19(6):529-37.PMID: 9181898 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study.

    Bergmann L, Fenchel K, Weidmann E, Enzinger HM, Jahn B, Jonas D, Mitrou PS.

    Cancer. 1993 Sep 1;72(5):1733-42.PMID: 8348502 [PubMed - indexed for MEDLINE]Related articles

    19.

    Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation.

    LaCasse EC, Bray MR, Patterson B, Lim WM, Perampalam S, Radvanyi LG, Keating A, Stewart AK, Buckstein R, Sandhu JS, Miller N, Banerjee D, Singh D, Belch AR, Pilarski LM, Gariépy J.

    Blood. 1999 Oct 15;94(8):2901-10.PMID: 10515895 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Weekly docetaxel in patients with pretreated metastatic breast cancer: a phase II trial.

    Mey U, Gorschlüter M, Ziske C, Kleinschmidt R, Glasmacher A, Schmidt-Wolf IG.

    Anticancer Drugs. 2003 Mar;14(3):233-8.PMID: 12634618 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity